Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng William Hong

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Medical Physics|September 4, 2025
4D-MRI at 0.55T for internal target volume delineation in liver radiation therapy planningXin Miao, Pan Su, Michael A Ohliger, et al.
AJR. American Journal of Roentgenology|April 16, 2025
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients With Metastatic Neuroendocrine Tumors: A Prospective StudyCheng William Hong, Yang Yang, Isabelle Remick, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
European Radiology|February 28, 2019
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observationsCheng William Hong, Charlie C Park, Adrija Mamidipalli, et al.
Abdominal Radiology (New York)|June 8, 2019
Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noiseCheng William Hong, Gavin Hamilton, Catherine Hooker, et al.
Abdominal Radiology (New York)|November 30, 2024
Performing liver imaging at a high level: quality and adequacy in LI-RADSCheng William Hong, Guilherme M Cunha, Takeshi Yokoo, et al.
EMBO Molecular Medicine|August 10, 2013
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaJung Eun Park, Hiu Fung Yuen, Jian Biao Zhou, et al.
Oncotarget|March 1, 2012
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in miceKe Guo, Jing Ping Tang, Li Jie, et al.
Abdominal Radiology (New York)|October 21, 2024
CT/MRI technical pitfalls for diagnosis and treatment response assessment using LI-RADS and how to optimizeOmar Kamal, Maryam Haghshomar, Jessica Yang, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 26, 2017
Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosisAdrija Mamidipalli, Gavin Hamilton, Paul Manning, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Medical Physics|September 4, 2025
4D-MRI at 0.55T for internal target volume delineation in liver radiation therapy planningXin Miao, Pan Su, Michael A Ohliger, et al.
AJR. American Journal of Roentgenology|April 16, 2025
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients With Metastatic Neuroendocrine Tumors: A Prospective StudyCheng William Hong, Yang Yang, Isabelle Remick, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
European Radiology|February 28, 2019
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observationsCheng William Hong, Charlie C Park, Adrija Mamidipalli, et al.
Abdominal Radiology (New York)|June 8, 2019
Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noiseCheng William Hong, Gavin Hamilton, Catherine Hooker, et al.
Abdominal Radiology (New York)|November 30, 2024
Performing liver imaging at a high level: quality and adequacy in LI-RADSCheng William Hong, Guilherme M Cunha, Takeshi Yokoo, et al.
EMBO Molecular Medicine|August 10, 2013
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaJung Eun Park, Hiu Fung Yuen, Jian Biao Zhou, et al.
Oncotarget|March 1, 2012
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in miceKe Guo, Jing Ping Tang, Li Jie, et al.
Abdominal Radiology (New York)|October 21, 2024
CT/MRI technical pitfalls for diagnosis and treatment response assessment using LI-RADS and how to optimizeOmar Kamal, Maryam Haghshomar, Jessica Yang, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 26, 2017
Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosisAdrija Mamidipalli, Gavin Hamilton, Paul Manning, et al.
Pageof 4